The Department of Health and Human Services will cancel contracts and pull funding for some vaccines that are being developed ...

The U.S. Department of Health and Human Services said on Tuesday it would wind down mRNA vaccine development activities under its biomedical research unit.The unit, Biomedical Advanced Research and ...

The US Department of Health and Human Services is ending contracts to develop vaccines using messenger RNA technology, ...

Pfizer is starting to execute on its turnaround plan and drug pipeline. 10 stocks we like better than Pfizer › Shares of the ...

Pfizer Q2 2025 earnings show 10% revenue growth, raised EPS guidance, strong R&D, and operational execution. Explore growth drivers and policy risks.

In an upward revision of its full-year guidance, Pfizer said it now expects adjusted earnings per share for 2025 to range between 2.90 dollars and 3.10 dollars, compared to its previous forecast of ...

First up, India has hit out at the United States and Europe over its imports of Russian oil, after President Donald Trump ...

CEO Albert Bourla said Tuesday he has a "special relationship" with President Trump, cemented during the COVID-19 pandemic ...

Aug 5 - Pfizer (NYSE:PFE) heads into its Q2 earnings release amid growing investor caution. Analysts expect revenue around ...

Pharmaceutical giant Pfizer (PFE) has reported financial results for this year’s second quarter that topped Wall Street forecasts. The New York City-based company announced earnings per share (EPS) of ...

So why would a government make it harder for older people to get vaccines against COVID, which dispatched 389 citizens from ...